Showing results (151-160 of 2,890) with videos related to

Sort By:
Pageof 289
Annals of the New York Academy of Sciences|June 15, 1996
Oxidative stress and Parkinson's diseaseA D Owen, A H Schapira, P Jenner, et al.
Neuropharmacology|May 1, 1994
An autoradiographic study of the differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on striatal and extrastriatal D-1 and D-2 dopamine receptors in the ratK K Gnanalingham, A J Hunter, P Jenner, et al.
Brain Research|June 14, 1991
Serotonergic sprouting in the neostriatum after intrastriatal transplantation of fetal ventral mesencephalonY Takeuchi, T Sawada, S Blunt, et al.
Neuroscience|December 1, 1987
An immunohistochemical study of the acute and long-term effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the marmosetC M Waters, S P Hunt, P Jenner, et al.
Neuroscience|July 1, 1994
Neurotensin, substance P, delta and mu opioid receptors are decreased in basal ganglia of Parkinson's disease patientsA Fernandez, M L de Ceballos, P Jenner, et al.
Brain Research|October 25, 1991
Effects of 6-hydroxydopamine lesions of the nigrostriatal pathway on striatal serotonin innervation in adult ratsY Takeuchi, T Sawada, S Blunt, et al.
Journal of Neural Transmission. Supplementum|January 1, 1997
Indices of oxidative stress in Parkinson's disease, Alzheimer's disease and dementia with Lewy bodiesA D Owen, A H Schapira, P Jenner, et al.
Annals of Neurology|January 1, 1992
Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. The Royal Kings and Queens Parkinson's Disease Research GroupD T Dexter, P Jenner, A H Schapira, et al.
Biochemical Pharmacology|May 11, 1995
Stimulation of adenylate cyclase activity by benzazepine D-1 dopamine agonists with varying efficacies in the 6-hydroxydopamine lesioned rat--relationship to circling behaviourK K Gnanalingham, A J Hunter, P Jenner, et al.
Psychopharmacology|February 1, 1995
The differential behavioural effects of benzazepine D1 dopamine agonists with varying efficacies, co-administered with quinpirole in primate and rodent models of Parkinson's diseaseK K Gnanalingham, A J Hunter, P Jenner, et al.
Pageof 289